To highlight its proven strategies for optimizing the management of high-cost specialty diseases and help serve the self-insurance marketplace, AscellaHealth, a specialty pharmacy benefit manager (SPBM), serving commercial, Medicare and Medicaid segments, will participate at SIIA’s National Conference & Expo
“The SIAA conference is an excellent platform for AscellaHealth to share its solutions with self-insured employers who face the challenges of providing costly care to plan members with chronic illness,” says Dea Belazi, president and CEO, AscellaHealth. “With the development of new technology and tools for addressing these challenges, employers are adopting our comprehensive drug management program, designed to provide an unprecedented level of control, transparency and accountability. For self-insured employers, this approach enables prescription cost containment, ensures appropriate medication utilization and monitors physician and pharmacy performance in real-time.”
The AscellaHealth model demonstrates specialized expertise and delivers value throughout the care continuum, empowering employer groups, unions and health plans to overcome the challenges of complex illness among plan members.
“As a specialty-focused pharmaceutical management company, AscellaHealth plays a pivotal role in getting patients the drugs they need at a price they can afford, relying on vast resources to negotiate on behalf of insurers and customers,” Belazi adds. “Our value-based program, combined with utilization management and clinical interventions based on active patient management, lead to cost control and usage predictability.”
About AscellaHealth
AscellaHealth, a specialty pharmacy benefit manager (SPBM), serving commercial, Medicare and Medicaid segments, offers high quality prescription drug benefit management services. Complemented by other customizable services, such as carved-out specialty pharmacy services and cost-savings programs, AscellaHealth provides a unique, proprietary service portfolio. Visit www.ascellahealth.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190926005022/en/
Source: AscellaHealth